Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Criteria of ineffectiveness of treatment with first-line therapy: how to use MRI results in decision making?]
Protein-based classifier to predict conversion from clinically isolated syndrome to multiple sclerosis.
Oral corticosteroids for multiple sclerosis relapse.
The rehabilitation of the multiple sclerosis patient.
Rituximab for tumefactive demyelination refractory to corticosteroids and plasma exchange.
Placebo and nocebo effects in the neurological practice.
Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy.
Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.
Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes.
Methods for identifying subject-specific abnormalities in neuroimaging data.
Disclosure of diagnosis of multiple sclerosis in the workplace positively affects employment status and job tenure.
Oligoclonal bands in multiple sclerosis patients: worse prognosis?
Current and emerging therapies for the treatment of multiple sclerosis: focus on cladribine.
Disease mechanisms in MS: Cell adhesion molecule MCAM on pathogenic T cells-a green light for CNS entry in multiple sclerosis.
Relation of Demographics and Reported Symptoms and Medication Use in Persons with Multiple Sclerosis.
Neurologic disease with pregnancy and considerations for the obstetric anesthesiologist.
Theiler's murine encephalomyelitis virus as an experimental model system to study the mechanism of blood-brain barrier disruption.
Network collapse and cognitive impairment in multiple sclerosis.
The Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation.
Adult myelination: wrapping up neuronal plasticity.
Multiple sclerosis: Reactivation of Epstein-Barr or herpes viruses not associated with MS relapse.
Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.
The treatment of neuromyelitis optica.
Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases.
Pages
« first
‹ previous
…
481
482
483
484
485
486
487
488
489
…
next ›
last »